SII has partnered with global pharma giant AstraZeneca and Oxford University for the vaccine candidate 'Covidshield'. "As of now we don't have anything in writing of how many doses the Government of India would purchase, but the indication is three to four hundred million doses by July 2021," Poonawalla said in a media interaction.from Healthcare/Biotech-Industry-Economic Times https://ift.tt/39mEOzF
via IFTTT
0 comments:
Post a Comment